Baidu
map

2021 ESMO临床实践指南:小细胞肺癌的诊断,治疗和随访

2021-04-19 欧洲肿瘤内科学会 Ann Oncol

2021年4月,欧洲肿瘤内科学会(ESMO)发布了小细胞肺癌的诊断,治疗和随访指南。本文主要针对小细胞肺癌的管理提供指导建议,内容涉及诊断,治疗和随访。

中文标题:

2021 ESMO临床实践指南:小细胞肺癌的诊断,治疗和随访

英文标题:

Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

发布机构:

欧洲肿瘤内科学会

发布日期:

2021-04-19

简要介绍:

2021年4月,欧洲肿瘤内科学会(ESMO)发布了小细胞肺癌的诊断,治疗和随访指南。本文主要针对小细胞肺癌的管理提供指导建议,内容涉及诊断,治疗和随访。

相关资料下载:
[AttachmentFileName(sort=1, fileName=2021 ESMO临床实践指南:小细胞肺癌的诊断,治疗和随访.pdf)] GetToolGuiderByIdResponse(projectId=1, id=10f961c00230619a, title=2021 ESMO临床实践指南:小细胞肺癌的诊断,治疗和随访, enTitle=Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, guiderFrom=Ann Oncol, authorId=0, author=, summary=2021年4月,欧洲肿瘤内科学会(ESMO)发布了小细胞肺癌的诊断,治疗和随访指南。本文主要针对小细胞肺癌的管理提供指导建议,内容涉及诊断,治疗和随访。, cover=https://img.medsci.cn/20211228/1640672899391_5579292.jpg, journalId=0, articlesId=null, associationId=14, associationName=欧洲肿瘤内科学会, associationIntro=欧洲肿瘤内科学会(ESMO,European Society for Medical Oncology )是1975年成立的非盈利组织,是欧洲领先的专业组织,致力于提高肿瘤内科的专业性,推进癌症治疗和护理的多学科诊疗方法。, copyright=0, guiderPublishedTime=Mon Apr 19 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2021年4月,欧洲肿瘤内科学会(ESMO)发布了小细胞肺癌的诊断,治疗和随访指南。本文主要针对小细胞肺癌的管理提供指导建议,内容涉及诊断,治疗和随访。</span></p>, tagList=[TagDto(tagId=428, tagName=肺癌), TagDto(tagId=1165, tagName=小细胞肺癌)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤, tenant=100), CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=1165, guiderKeyword=小细胞肺癌, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=1850, appHits=295, showAppHits=0, pcHits=497, showPcHits=1553, likes=0, shares=45, comments=9, approvalStatus=1, publishedTime=Tue Dec 28 14:26:40 CST 2021, publishedTimeString=2021-04-19, pcVisible=1, appVisible=1, editorId=5579292, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=FUNNYMAN, createdTime=Tue Dec 28 14:34:18 CST 2021, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Thu Jan 04 16:23:53 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 ESMO临床实践指南:小细胞肺癌的诊断,治疗和随访.pdf)])
2021 ESMO临床实践指南:小细胞肺癌的诊断,治疗和随访.pdf
下载请点击:
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1208582, encodeId=29061208582dd, content=好资源,学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=00ec8098175, createdName=ms3000000771933475, createdTime=Mon Apr 04 18:42:27 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200643, encodeId=cb3c120064318, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=198f5456588, createdName=ms3000000190198551, createdTime=Tue Mar 08 19:28:53 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196186, encodeId=11941196186b6, content=学习谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39415160640, createdName=146b6cbem78暂无昵称, createdTime=Tue Feb 22 19:46:35 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186096, encodeId=63b611860960b, content=小细胞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/FB3TvKpvrtujQ2N7qVxKiaiaCaWyEhaVeeYp60ibK2Ydhrtsg2JSUm4mjfN0P0lPJP9VhGtZFFFUKuJNbPOibvDPkQ/132, createdBy=f4fe2307331, createdName=恒心, createdTime=Wed Jan 19 18:19:07 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185248, encodeId=4873118524820, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3da35408927, createdName=ms3000002057134316, createdTime=Mon Jan 17 17:05:16 CST 2022, time=2022-01-17, status=1, ipAttribution=)]
    2022-04-04 ms3000000771933475

    好资源,学习!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1208582, encodeId=29061208582dd, content=好资源,学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=00ec8098175, createdName=ms3000000771933475, createdTime=Mon Apr 04 18:42:27 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200643, encodeId=cb3c120064318, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=198f5456588, createdName=ms3000000190198551, createdTime=Tue Mar 08 19:28:53 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196186, encodeId=11941196186b6, content=学习谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39415160640, createdName=146b6cbem78暂无昵称, createdTime=Tue Feb 22 19:46:35 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186096, encodeId=63b611860960b, content=小细胞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/FB3TvKpvrtujQ2N7qVxKiaiaCaWyEhaVeeYp60ibK2Ydhrtsg2JSUm4mjfN0P0lPJP9VhGtZFFFUKuJNbPOibvDPkQ/132, createdBy=f4fe2307331, createdName=恒心, createdTime=Wed Jan 19 18:19:07 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185248, encodeId=4873118524820, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3da35408927, createdName=ms3000002057134316, createdTime=Mon Jan 17 17:05:16 CST 2022, time=2022-01-17, status=1, ipAttribution=)]
    2022-03-08 ms3000000190198551

    学习学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1208582, encodeId=29061208582dd, content=好资源,学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=00ec8098175, createdName=ms3000000771933475, createdTime=Mon Apr 04 18:42:27 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200643, encodeId=cb3c120064318, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=198f5456588, createdName=ms3000000190198551, createdTime=Tue Mar 08 19:28:53 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196186, encodeId=11941196186b6, content=学习谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39415160640, createdName=146b6cbem78暂无昵称, createdTime=Tue Feb 22 19:46:35 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186096, encodeId=63b611860960b, content=小细胞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/FB3TvKpvrtujQ2N7qVxKiaiaCaWyEhaVeeYp60ibK2Ydhrtsg2JSUm4mjfN0P0lPJP9VhGtZFFFUKuJNbPOibvDPkQ/132, createdBy=f4fe2307331, createdName=恒心, createdTime=Wed Jan 19 18:19:07 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185248, encodeId=4873118524820, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3da35408927, createdName=ms3000002057134316, createdTime=Mon Jan 17 17:05:16 CST 2022, time=2022-01-17, status=1, ipAttribution=)]
    2022-02-22 146b6cbem78暂无昵称

    学习谢谢

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1208582, encodeId=29061208582dd, content=好资源,学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=00ec8098175, createdName=ms3000000771933475, createdTime=Mon Apr 04 18:42:27 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200643, encodeId=cb3c120064318, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=198f5456588, createdName=ms3000000190198551, createdTime=Tue Mar 08 19:28:53 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196186, encodeId=11941196186b6, content=学习谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39415160640, createdName=146b6cbem78暂无昵称, createdTime=Tue Feb 22 19:46:35 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186096, encodeId=63b611860960b, content=小细胞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/FB3TvKpvrtujQ2N7qVxKiaiaCaWyEhaVeeYp60ibK2Ydhrtsg2JSUm4mjfN0P0lPJP9VhGtZFFFUKuJNbPOibvDPkQ/132, createdBy=f4fe2307331, createdName=恒心, createdTime=Wed Jan 19 18:19:07 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185248, encodeId=4873118524820, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3da35408927, createdName=ms3000002057134316, createdTime=Mon Jan 17 17:05:16 CST 2022, time=2022-01-17, status=1, ipAttribution=)]
    2022-01-19 恒心

    小细胞

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1208582, encodeId=29061208582dd, content=好资源,学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=00ec8098175, createdName=ms3000000771933475, createdTime=Mon Apr 04 18:42:27 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200643, encodeId=cb3c120064318, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=198f5456588, createdName=ms3000000190198551, createdTime=Tue Mar 08 19:28:53 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196186, encodeId=11941196186b6, content=学习谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39415160640, createdName=146b6cbem78暂无昵称, createdTime=Tue Feb 22 19:46:35 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186096, encodeId=63b611860960b, content=小细胞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/FB3TvKpvrtujQ2N7qVxKiaiaCaWyEhaVeeYp60ibK2Ydhrtsg2JSUm4mjfN0P0lPJP9VhGtZFFFUKuJNbPOibvDPkQ/132, createdBy=f4fe2307331, createdName=恒心, createdTime=Wed Jan 19 18:19:07 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185248, encodeId=4873118524820, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3da35408927, createdName=ms3000002057134316, createdTime=Mon Jan 17 17:05:16 CST 2022, time=2022-01-17, status=1, ipAttribution=)]
    2022-01-17 ms3000002057134316

    学习

    0

拓展阅读

2015 ASCO/ACCP:小细胞肺癌治疗指南

美国临床肿瘤学会(ASCO,American Society of Clinical Oncology) · 2016-05-30

2018 CCO指南:小细胞肺癌的初期管理以及胸部放疗和一线化疗的作用

加拿大安大略癌症治疗中心(CCO,Cancer Care Ontario) · 2018-07-11

2020 ASTRO临床实践指南:小细胞肺癌放射治疗

美国放射治疗及肿瘤学会(ASTRO,American Society for Therapeutic Radiology and Oncology) · 2020-03-23

2020 ESTRO-ACROP指南:小细胞肺癌胸部放射治疗的靶区定义

欧洲放射肿瘤学学会(ESTRO,European Society of Radiotherapy & Oncology) · 2020-07-13

ASCO和ASTRO指南:小细胞肺癌的放疗

美国临床肿瘤学会(ASCO,American Society of Clinical Oncology) · 2021-01-21

2022 NICE指南更新:肺癌的诊断和管理[NG122]

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2022-09-22

Baidu
map
Baidu
map
Baidu
map